Construction and Clinical Validation Study of a Prediction Model for Depression After Ischemic Stroke

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMin Su

About this trial

Post-stroke depression (PSD) is the most common neuropsychiatric disorder after a stroke, with an incidence rate of 20% to 60%. PSD is not only associated with higher mortality rates, poorer recovery, more obvious cognitive impairments, greater economic burdens, and lower quality of life, but also brings additional medical expenses and care pressure to families. Society also needs to bear higher medical costs. Currently, the early diagnosis of PSD is difficult, which may lead to poor prognosis after stroke. This study aims to utilize machine learning technology to integrate multi-dimensional indicators of patients with ischemic stroke, establish a risk prediction model for PSD, and assist in early, accurate, and individualized assessment of PSD risk in clinical practice.

Eligibility criteria

Qualifiers

Patients with acute ischemic stroke;

Admission within 7 days of symptom onset;

The patient and/or the family members sign a written informed consent form.

Disqualifiers

Confusion of consciousness,severe cognitive impairment, etc

Individuals with a history of depression, schizophrenia, bipolar disorder, etc;

Individuals unable to participate in neuropsychological examinations due to hearing im pairments, lack of coordination, or neurological deficits, including se vere aphasia.

Trial design

Treatments tested in this trial

  • Group patients based on whether they have been diagnosed with PSD.

Treatment groups

488 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Min Su

Lead sponsor

First Affiliated Hospital of Chongqing Medical University

Sponsor institution

Chongqing Traditional Chinese Medicine Hospital

Collaborator